X-ray Powder Diffraction Pattern Indexing for Pharmaceutical Applications - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

X-ray Powder Diffraction Pattern Indexing for Pharmaceutical Applications
Indexing is the process of determining the size, shape and symmetry of the crystallographic unit cell for a crystalline component responsible for a set of peaks in an X-ray powder-diffraction (XRPD) pattern. The authors discuss the valuable information that can be obtained from indexing and its applications in routine screening and analysis of solid forms.

Pharmaceutical Technology
Volume 37, Issue 1, pp. 56-61

Comparisons with single crystal data

Figure 2: Comparison of room temperature X-ray powder-diffraction (XRPD) pattern (red) and calculated XRPD pattern from the single crystal structure at 120 K (blue) for the 1:1 cocrystal of p-coumaric acid and nicotinamide. The maximum intensity of both patterns is scaled to 10,000 counts for ease of comparison.
Unit cells generally expand with increasing temperature. Indexing can be used to account for thermal expansion when comparing a calculated XRPD pattern that was generated from a single crystal data collection at low temperature to an experimental XRPD pattern that was collected at room temperature. Single crystal data are often collected at low temperatures to improve the quality of the structure (1). Anisotropic thermal expansion may cause a calculated XRPD pattern from a single crystal structure to differ from the experimental XRPD pattern. When the experimental XRPD pattern is indexed, the unit-cell parameters can be compared with the unit-cell parameters from the single crystal structure determination to assess whether the forms are the same. Forms with different symmetries are necessarily different. If the indexing solution from the single crystal structure and the XRPD indexing solution share the same symmetry and similar unit-cell parameters, however, the differences may be attributed to thermal expansion.

Table II: Comparison with single crystal structure for 1:1 p-coumaric acid/nicotinamide cocrystal.
Figure 2 presents two XRPD patterns for the 1:1 cocrystal of p-coumaric acid and nicotinamide discussed previously. The experimental powder pattern in red was collected at room temperature; whereas, the pattern calculated from the single crystal structure at 120 K is in blue. Although the patterns share similarities, peak shifting and changes in relative peak intensity make the patterns look different, particularly at higher scattering angles, 2θ. Unitcell data corresponding to the same state points are given in Table II. The unit cells share the same space group, which is a necessary condition for being of the same form. Also, the unitcell lengths are in similar proportions but are somewhat longer at room temperature. In other systems, one or more of the cell parameters may shrink with increasing temperature. An overall increase in volume of a few percent upon warming from 120 K to room temperature is common. The example in Table II includes a shear component, which also contributes to changes in XRPD patterns for triclinic and monoclinic crystals.

Preferred orientation effects

XRPD relies on a uniform distribution of crystallites to produce a representative pattern. Crystals with anisotropic morphologies, such as needles or plates, tend to align relative to the specimen holder during XRPD analysis, which leads to a nonuniform distribution of crystal orientations. As a result, peaks may become significantly stronger, weaker, or even too weak to be observed. This phenomenon is called preferred orientation. Because preferred orientation is a result of the interaction between crystals with a particular morphology and a specimen holder with a particular geometry, changes in the specimen, specimen preparation, specimen holder and/or diffractometer geometry may lead to XRPD patterns with different relative peak intensities. These differences can be mistakenly attributed to multiple forms. Indexing of XRPD patterns may be used to show that the unit-cell symmetry and geometry are consistent, indicating that the same crystal form is present despite preferred orientation effects.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here